期刊文献+

胸腔积液中CYFRA21-1、NSE、CEA的水平与肺癌组织学分型及TNM分期的关系 被引量:2

Relationship Between the Pleural Effusion Levels of CYFRA21-1,NSE,CEA and Histological Types as well as TNM Stages of the Tumor in Patients with Lung Cancer
下载PDF
导出
摘要 目的:探讨胸腔积液中CYFRA21-1、NSE、CEA的水平对肺癌的诊断价值以及与肺癌组织学分型、TNM分期的关系。方法:采用电化学发光法和化学发光法分别检测253例肺癌,39例其他恶性肿瘤以及36例肺结核患者胸腔积液中CYFRA21-1、NSE和CEA的水平。结果:肺癌组胸腔积液中CYFRA21-1、NSE、CEA水平明显高于其他恶性肿瘤组和肺结核组(P<0.01);CYFRA21-1、NSE以及CEA分别在肺鳞癌、小细胞肺癌以及肺腺癌的胸腔积液中表达最高(P分别<0.01、0.01和0.05),并且随TNM分期增加而增高。结论:检测胸腔积液中CYFRA21-1、NSE、CEA水平对肺癌的鉴别诊断、组织学分型以及TNM分期有重要价值。 Objective To investigate the diagnostic value of detection of cytokeratin fragment 19(CYFRA21-1),neuron specific enolase(NSE),carcinoembryonic antigen(CEA) in malignant pleural effusion,as well as the relationship between the levels of these tumor markers and the histological types,TNM stages of the tumor in patients with lung cancer.Methods Pleural effusion levels of CYFRA21-1,NSE were detected with electrochemiluminescence immunoassay and CEA were detected with chemiluminescence immunoassay in 328 patients(253 lung cancer,39 other cancers and 36 tuberculosis).Results The pleural effusion levels of CYFRA21-1,NSE and CEA in patients with lung cancer were significantly higher than those in patients with other cancers and tuberculosis(P0.01).The levels of CYFRA21-1 in squamous cell carcinoma,NSE in small cell lung cancer(SCLC) and CEA in adenocarcinoma was the highest one respectively(P0.01,0.01 and 0.05 respectively).The levels of these tumor markers in patients with lung cancer increased as the TNM stages advanced.Conclusion The detections of CYFRA21-1,NSE and CEA in pleural effusion were of differential diagnostic value and might be used to assess histological types and TNM stages of lung cancer.
出处 《放射免疫学杂志》 CAS 2010年第1期46-48,共3页 Journal of Radioimmanology
关键词 肺癌 胸腔积液 细胞角蛋白19 神经特异性烯醇化酶 癌胚抗原 组织学分型 TNM分期 lung cancer pleural effusion CYFRA21-1 NSE CEA histological types TNM stages
  • 相关文献

参考文献9

  • 1Matas F, Matas O, Metlntas M, et al. Diagnostic value of CEA, CA15-3, CA19-9, CYFRA21-1, NSE and TSA assay in pleural effusions [J]. BrJCancer, 2001, 31(1) :9-16.
  • 2Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokcratin 19 fragments in patients with effusions from primary lung cancer [ J ]. Chest, 2005, 128(4) : 2298-2303.
  • 3Hatzakis KD, Fmudarakis ME, Boures D, et al. Prognostic value of serum tumor markers in patients with lung cancer[ J]. Respiration, 2002, 69(1) : 25-29.
  • 4李红,万自芬.肿瘤标志物CEA、CYFRA21-1联检在非小细胞肺癌中的诊断价值[J].放射免疫学杂志,2006,19(5):432-433. 被引量:20
  • 5Karnak D, Ulubay G, Kayacan O, et al. Evaluation of CYFRA21-1 : a potential tumor marker for non -small cell lung carcinomas [ J ]. Lung, 2001, 179(1) : 57-63.
  • 6Molina R, Filella X, Auge JM, et al. Tumor markers (CEA, CA 125 CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors [ J ]. Tumour Biol, 2003, 24(4) : 209-218.
  • 7Ando S, Suzuki M, Yamamoto N, et al. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer [J]. Anticancer Res, 2004, 24(3B) : 1941-1946.
  • 8Pujol JL, Boher JM, Grenier J, et al. Neuron specific enolase and prognosis of non-small cell lung cancer : prospective study in 621 patients [J]. Lung Cancer, 2001,31(2-3) : 221-228.
  • 9Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer[ J]. Anticancer Res, 2001, 21 (4B) : 3085-3095.

二级参考文献3

共引文献19

同被引文献14

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部